Stay Informed on Corporate Sustainability
Explore industry news, insights, and updates from the Pharma Industry Awards.
Partnering for Success: Tandem Delivers End-to-End Project Excellence in the Life Science Sector
Tandem Project Management delivers end-to-end project excellence for life science companies, combining technical expertise, regulatory compliance, and operational agility to drive innovation and measurable results.
Pharmaceutical and Molecular Biotechnology Research Centre wins Research & Development Achievement Award at Pharma Industry Awards 2025
Applauded for its pioneering research in 2025, the Pharmaceutical and Molecular Biotechnology Research Centre won the Research & Development Achievement Award at the Pharma Industry Awards 2025, setting a benchmark as the sector looks toward 2026.
Vect-Horus collaborates with OliX to advance CNS siRNA therapies
Vect-Horus and OliX Pharmaceuticals have launched a CNS-focused collaboration to evaluate siRNA delivery via blood-brain barrier shuttle technology. The partnership aims to accelerate RNAi-based therapeutics for hard-to-reach CNS targets.
Insilico partners with Qilu to develop cardiometabolic therapies
Insilico Medicine has partnered with Qilu Pharmaceutical to develop cardiometabolic therapies using AI-driven small molecule design. The $120m deal includes development milestones, royalties, and potential out-licensing revenue exceeding $2bn.
McCabes Pharmacy modernises operations with full digitisation
Ireland’s largest pharmacy group McCabes Pharmacy has completed a company-wide digitisation programme covering auditing, stock monitoring, internal communications, and major projects. The strategy has improved compliance, efficiency, and asset protection across 110 stores.
Pharma Frontiers
Innovation, operational excellence, and workforce development continue to accelerate the pharmaceutical and life sciences sector. Organisations that combine technical expertise, strategic vision, and collaborative approaches are setting benchmarks for global impact and sustainable growth. In reflection on last year’s landmark success, ‘Viatris Little Island wins Pharma Project of the Year – Large at Pharma Industry Awards 2025’ highlights the precision and resilience required to deliver complex engineering projects in live production environments. That achievement reinforces how large-scale operational excellence can shape standards for high-impact pharmaceutical initiatives as the 2026 awards cycle approaches. Moreover, ‘SGS’s Expanding Role in Biopharma Quality, Safety, and Scientific Assurance Across Global Network’ illustrates how integrated scientific and regulatory expertise underpins global biopharma innovation. By supporting quality, safety, and compliance across diverse programmes, SGS is enabling companies to accelerate advanced therapies with confidence. Meanwhile, ‘UCC and BioPharmaChem Skillnet bring the future of biopharmaceuticals to learners’ reflects the growing importance of workforce development in emerging technologies. Providing accessible, advanced training ensures that the sector has the skills needed to meet next-generation medicine challenges. These stories underscore how operational leadership, scientific excellence, and talent development are shaping the future of global life sciences.
Viatris Little Island wins Pharma Project of the Year – Large at Pharma Industry Awards 2025
Celebrated for its excellence last year, Viatris Little Island was named Pharma Project of the Year – Large at the Pharma Industry Awards 2025, setting a benchmark for complex pharma projects as the 2026 awards cycle approaches.
SGS’s Expanding Role in Biopharma Quality, Safety, and Scientific Assurance Across Global Network
SGS details how its global scientific and regulatory expertise supports quality and safety in advanced biopharma therapies, from development to commercialisation.
UCC and BioPharmaChem Skillnet bring the future of biopharmaceuticals to learners
As biopharmaceutical innovation accelerates, UCC and BioPharmaChem Skillnet open registrations for the 2026 Certificate in Introduction to Biopharmaceuticals and Advanced Personalised Therapies.
Zen LifeSciences invests P1.2 billion (€17.2 million) to expand pharma operations in Tarlac
Philippine-based Zen LifeSciences is establishing operations in Tarlac’s Luisita Industrial Park Special Economic Zone. The project includes FDA-certified biopharmaceutical production, generating jobs and boosting the country’s pharmaceutical manufacturing sector.
Discover What's Happening
Explore our newsletters
Join our Newsletter to receive the latest industry trends, expert tips, and exclusive insights delivered straight to your inbox!

Sort by


.png)

